Figure 13.5. Age-specific incidence rates for cancers of the endometrium in women using estrogen replacement therapy (ERT) (A) and combination oral contraceptives (OCs) (B) for 5 years.
Figure 13.5. Age-specific incidence rates for cancers of the endometrium in women using estrogen replacement therapy (ERT) (A) and combination oral contraceptives (OCs) (B) for 5 years.

Figure 13.5

Age-specific incidence rates for cancers of the endometrium in women using estrogen replacement therapy (ERT) (A) and combination oral contraceptives (OCs) (B) for 5 years. Data are from the U.K. Birmingham Cancer Registry for the years 1968 to 1972. These data largely avoid problems arising from the high hysterectomy and oophorectomy rates in the United States, which artificially distort the age-incidence curves. Dots, actual incidence data; solid lines markednormal,” mathematic models predicting these rates from the major known risk factors for these cancers.13

From: Chapter 13, Hormones and the Etiology of Cancer

Cover of Holland-Frei Cancer Medicine
Holland-Frei Cancer Medicine. 5th edition.
Bast RC Jr, Kufe DW, Pollock RE, et al., editors.
Hamilton (ON): BC Decker; 2000.
© 2000, BC Decker Inc.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.